SCHEMBL470568

SCHEMBL470568

Cc1ccc(F)c([C@H]2CN(Cc3ccccc3)C[C@@H]2NO)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.42
HTT P42858 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CCR5 P51681 1/20 0.42
BCHE P06276 2/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
ACHE P22303 3/20 0.40
BACE1 P56817 3/20 0.40
DPP4 P27487 1/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
CHRM4 P08173 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13186825 0.88 DRD2 (0.53) MEN1KMT2ACCR5BCHEDRD2
SCHEMBL470773 0.86 DRD2 (0.41) CCR5BCHEDRD2DRD3ACHE
SCHEMBL470519 0.85 DPP4 (0.48) CCR5BCHEDRD2DRD3ACHE
SCHEMBL470646 0.85 DRD2 (0.45) DRD2DRD3DPP4ALDH1A1SIGMAR1
SCHEMBL12064586 0.83 KDM1A (0.46) MEN1KMT2AALDH1A1SIGMAR1CHRM4
SCHEMBL470654 0.82 DPP4 (0.60) NPSR1HTTMEN1KMT2ACCR5
SCHEMBL459501 0.82 KMT2A (0.44) NPSR1HTTMEN1KMT2ADRD2
SCHEMBL459499 0.82 KMT2A (0.44) NPSR1HTTMEN1KMT2ADRD2
SCHEMBL13186638 0.81 DRD2 (0.50) KMT2ACCR5BCHEDRD2DRD3
SCHEMBL463330 0.77 NPSR1 (0.43) NPSR1HTTMEN1KMT2ACCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed